Therapeutic advances in tremor

Movement Disorders

Volumn 30, Issue 11, 2015, Pages 1557-1565

  Fasano, Alfonso ^a   Deuschl, Günther ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Deep brain stimulation; Drugs, MRI guided focused ultrasound lesioning; Essential tremor; Surgery; Treatment; Tremor

Indexed keywords

1,3 DIMETHOXYMETHYL 5,5 DIPHENYLBARBITURIC ACID; ALPRAZOLAM; ATENOLOL; BARBITURIC ACID DERIVATIVE; BOTULINUM TOXIN; CANNABINOID; CLONAZEPAM; CLOZAPINE; ETIRACETAM; FAMPRIDINE; FLUNARIZINE; GABAPENTIN; NADOLOL; NATALIZUMAB; NIMODIPINE; OCTANOL; PREGABALIN; PRIMIDONE; PROPRANOLOL; SOTALOL; TOPIRAMATE; UNCLASSIFIED DRUG;

ANXIETY DISORDER; BRAIN DEPTH STIMULATION; CEREBELLAR ATAXIA; DISEASE EXACERBATION; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; ELECTROSTIMULATION; ESSENTIAL TREMOR; HUMAN; MAGNETIC STIMULATION; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NEUROPROSTHESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SUICIDAL IDEATION; TREMOR; ULTRASOUND; CLINICAL TRIAL (TOPIC); PROCEDURES;

CLINICAL TRIALS AS TOPIC; DEEP BRAIN STIMULATION; HUMANS; NEURAL PROSTHESES; OCTANOLS; TREMOR;

EID: 84941601037     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26383     Document Type: Review

References (74)

1. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor Ad Hoc Scientific Committee. Mov Disord 1998;13(Suppl 3):2-23.
2. Deuschl G, Raethjen J, Hellriegel H, Elble R. Treatment of patients with essential tremor. Lancet Neurol 2011;10:148-161.
3. Zesiewicz TA, Elble RJ, Louis ED, et al. Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology 2011;77:1752-1755.
4. Zappia M, Albanese A, Bruno E, et al. Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association. J Neurol 2013;260:714-740.
5. Louis ED, Rios E, Henchcliffe C. How are we doing with the treatment of essential tremor (ET)?: Persistence of patients with ET on medication: data from 528 patients in three settings. Eur J Neurol 2010;17:882-884.
6. Nahab FB, Handforth A, Brown T, et al. Octanoic acid suppresses harmaline-induced tremor in mouse model of essential tremor. Neurotherapeutics 2012;9:635-638.
7. Bushara KO, Goldstein SR, Grimes GJ, Jr., Burstein AH, Hallett M. Pilot trial of 1-octanol in essential tremor. Neurology 2004;62:122-124.
8. Shill HA, Bushara KO, Mari Z, Reich M, Hallett M. Open-label dose-escalation study of oral 1-octanol in patients with essential tremor. Neurology 2004;62:2320-2322.
9. Haubenberger D, Nahab FB, Voller B, Hallett M. Treatment of essential tremor with long-chain alcohols: still experimental or ready for prime time? Tremor Other Hyperkinet Mov (N Y) 2014;4. DOI: 10.7916/D8RX991R
10. Haubenberger D, McCrossin G, Lungu C, et al. Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study. Neurology 2013;80:933-940.
11. Zesiewicz TA, Sullivan KL, Hinson V, et al. Multisite, double-blind, randomized, controlled study of pregabalin for essential tremor. Mov Disord 2013;28:249-250.
12. Hadj Tahar A, Chuang R, Steeves T, Jog M, Lang A, Grimes D. Efficacy and safety of T2000 in older patients with essential tremor. Parkinsonism Relat Disord 2013;19:485-486.
13. Bahgat D, Magill ST, Berk C, McCartney S, Burchiel KJ. Thalamotomy as a treatment option for tremor after ineffective deep brain stimulation. Stereotact Funct Neurosurg 2013;91:18-23.
14. Campbell AM, Glover J, Chiang VL, Gerrard J, Yu JB. Gamma knife stereotactic radiosurgical thalamotomy for intractable tremor: A systematic review of the literature. Radiother Oncol 2015;114:296-301.
15. Siderowf A, Gollump SM, Stern MB, Baltuch GH, Riina HA. Emergence of complex, involuntary movements after gamma knife radiosurgery for essential tremor. Mov Disord 2001;16:965-967.
16. Young RF, Li F, Vermeulen S, Meier R. Gamma knife thalamotomy for treatment of essential tremor: long-term results. J Neurosurg 2010;112:1311-1317.
17. van der Kooij SM, Ankum WM, Hehenkamp WJ. Review of nonsurgical/minimally invasive treatments for uterine fibroids. Curr Opin Obstet Gynecol 2012;24:368-375.
18. Dong X, Yang Z. High-intensity focused ultrasound ablation of uterine localized adenomyosis. Curr Opin Obstet Gynecol 2010;22:326-330.
19. Warmuth M, Johansson T, Mad P. Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer. Eur Urol 2010;58:803-815.
20. Christian E, Yu C, Apuzzo ML. Focused ultrasound: relevant history and prospects for the addition of mechanical energy to the neurosurgical armamentarium. World Neurosurg 2014;82:354-365.
21. Lipsman N, Schwartz ML, Huang Y, et al. MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study. Lancet Neurol 2013;12:462-468.
22. Elias WJ, Huss D, Voss T, et al. A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med 2013;369:640-648.
23. Chang WS, Jung HH, Kweon EJ, Zadicario E, Rachmilevitch I, Chang JW. Unilateral magnetic resonance guided focused ultrasound thalamotomy for essential tremor: practices and clinicoradiological outcomes. J Neurol Neurosurg Psychiatry 2015;86:257-264.
24. Hyam JA, Pereira EA, McCulloch P, et al. Implementing novel trial methods to evaluate surgery for essential tremor. Br J Neurosurg 2015:1-6.
25. Limousin P, Speelman JD, Gielen F, Janssens M. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry 1999;66:289-296.
26. Shih LC, LaFaver K, Lim C, Papavassiliou E, Tarsy D. Loss of benefit in VIM thalamic deep brain stimulation (DBS) for essential tremor (ET): how prevalent is it? Parkinsonism Relat Disord 2013;19:676-679.
27. Borretzen MN, Bjerknes S, Saehle T, et al. Long-term follow-up of thalamic deep brain stimulation for essential tremor: patient satisfaction and mortality. BMC Neurol 2014;14:120.
28. Baizabal-Carvallo JF, Kagnoff MN, Jimenez-Shahed J, Fekete R, Jankovic J. The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond. J Neurol Neurosurg Psychiatry 2014;85:567-572.
29. Verla T, Marky A, Farber H, et al. Impact of advancing age on post-operative complications of deep brain stimulation surgery for essential tremor. J Clin Neurosci 2015;22:872-876.
30. Groppa S, Herzog J, Falk D, Riedel C, Deuschl G, Volkmann J. Physiological and anatomical decomposition of subthalamic neurostimulation effects in essential tremor. Brain 2014;137:109-121.
31. Barbe MT, Dembek TA, Becker J, et al. Individualized current-shaping reduces DBS-induced dysarthria in patients with essential tremor. Neurology 2014;82:614-619.
32. Moscovich M, Morishita T, Foote KD, Favilla CG, Chen ZP, Okun MS. Effect of lead trajectory on the response of essential head tremor to deep brain stimulation. Parkinsonism Relat Disord 2013;19:789-794.
33. Favilla CG, Topiol DD, Zesiewicz TA, et al. Impact of discontinuing tremor suppressing medications following thalamic deep brain stimulation. Parkinsonism Relat Disord 2013;19:171-175.
34. Popa T, Russo M, Vidailhet M, et al. Cerebellar rTMS stimulation may induce prolonged clinical benefits in essential tremor, and subjacent changes in functional connectivity: an open label trial. Brain Stimul 2013;6:175-179.
35. Chuang WL, Huang YZ, Lu CS, Chen RS. Reduced cortical plasticity and GABAergic modulation in essential tremor. Mov Disord 2014;29:501-507.
36. Picillo M, Moro E, Edwards M, Di Lazzaro V, Lozano AM, Fasano A. Subdural continuous theta burst stimulation of the motor cortex in essential tremor. Brain Stimul 2015;8:840-842.
37. Gironell A, Martinez-Horta S, Aguilar S, et al. Transcranial direct current stimulation of the cerebellum in essential tremor: a controlled study. Brain Stimul 2014;7:491-492.
38. Rahimi F, Bee C, Debicki D, Roberts AC, Bapat P, Jog M. Effectiveness of BoNT A in Parkinson's disease upper limb tremor management. Can J Neurol Sci 2013;40:663-669.
39. Lotan I, Treves TA, Roditi Y, Djaldetti R. Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study. Clin Neuropharmacol 2014;37:41-44.
40. Brittain JS, Probert-Smith P, Aziz TZ, Brown P. Tremor suppression by rhythmic transcranial current stimulation. Curr Biol 2013;23:436-440.
41. Baumann CR, Imbach LL, Baumann-Vogel H, Uhl M, Sarnthein J, Surucu O. Interleaving deep brain stimulation for a patient with both Parkinson's disease and essential tremor. Mov Disord 2012;27:1700-1701.
42. Koppel BS, Brust JC, Fife T, et al. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2014;82:1556-1563.
43. Kim SD, Yiannikas C, Mahant N, Vucic S, Fung VS. Treatment of proximal upper limb tremor with botulinum toxin therapy. Mov Disord 2014;29:835-838.
44. Kobayashi K, Katayama Y, Oshima H, et al. Multitarget, dual-electrode deep brain stimulation of the thalamus and subthalamic area for treatment of Holmes' tremor. J Neurosurg 2014;120:1025-1032.
45. Sitsapesan HA, Holland P, Oliphant Z, et al. Deep brain stimulation for tremor resulting from acquired brain injury. J Neurol Neurosurg Psychiatry 2014;85:811-815.
46. Seritan AL, Nguyen DV, Mu Y, et al. Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2014;75:264-271.
47. Mehanna R, Itin I. Which approach is better: bilateral versus unilateral thalamic deep brain stimulation in patients with fragile X-associated tremor ataxia syndrome. Cerebellum 2014;13:222-225.
48. Oyama G, Thompson A, Foote KD, et al. Deep brain stimulation for tremor associated with underlying ataxia syndromes: a case series and discussion of issues. Tremor Other Hyperkinet Mov (N Y) 2014;4:228.
49. Freund HJ, Barnikol UB, Nolte D, et al. Subthalamic-thalamic DBS in a case with spinocerebellar ataxia type 2 and severe tremor: An unusual clinical benefit. Mov Disord 2007;22:732-735.
50. Lefranc M, Manto M, Merle P, et al. Targeting the red nucleus for cerebellar tremor. Cerebellum 2014;13:372-377.
51. Espay AJ, Edwards MJ, Oggioni GD, et al. Tremor retrainment as therapeutic strategy in psychogenic (functional) tremor. Parkinsonism Relat Disord 2014;20:647-650.
52. Garcin B, Roze E, Mesrati F, et al. Transcranial magnetic stimulation as an efficient treatment for psychogenic movement disorders. J Neurol Neurosurg Psychiatry 2013;84:1043-1046.
53. Fasano A, Bove F, Lang AE. The treatment of dystonic tremor: a systematic review. J Neurol Neurosurg Psychiatry 2014;85:759-769.
54. Bertram K, Sirisena D, Cowey M, Hill A, Williams DR. Safety and efficacy of botulinum toxin in primary orthostatic tremor. J Clin Neurosci 2013;20:1503-1505.
55. Yaltho TC, Ondo WG. Orthostatic tremor: a review of 45 cases. Parkinsonism Relat Disord 2014;20:723-725.
56. Miwa H, Kondo T. T-type calcium channel as a new therapeutic target for tremor. Cerebellum 2011;10:563-569.
57. Choi KH. The design and discovery of T-type calcium channel inhibitors for the treatment of central nervous system disorders. Expert Opin Drug Discov 2013;8:919-931.
58. Caputo F, Skala K, Mirijello A, et al. Sodium oxybate in the treatment of alcohol withdrawal syndrome: a randomized double-blind comparative study versus oxazepam. The GATE 1 trial. CNS Drugs 2014;28:743-752.
59. Agundez JA, Jimenez-Jimenez FJ, Alonso-Navarro H, Garcia-Martin E. The potential of LINGO-1 as a therapeutic target for essential tremor. Expert Opin Ther Targets 2015:1-10.
60. Basu I, Graupe D, Tuninetti D, et al. Pathological tremor prediction using surface electromyogram and acceleration: potential use in 'ON-OFF' demand driven deep brain stimulator design. J Neural Eng 2013;10:036019.
61. Cagnan H, Brittain JS, Little S, et al. Phase dependent modulation of tremor amplitude in essential tremor through thalamic stimulation. Brain 2013;136:3062-3075.
62. Yamamoto T, Katayama Y, Ushiba J, et al. On-demand control system for deep brain stimulation for treatment of intention tremor. Neuromodulation 2013;16:230-235; discussion 235.
63. Collins-Praino LE, Paul NE, Ledgard F, et al. Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism. Eur J Neurosci 2013;38:2183-2191.
64. Gallego JA, Rocon E, Belda-Lois JM, et al. Design and validation of a neuroprosthesis for the treatment of upper limb tremor. Conf Proc IEEE Eng Med Biol Soc 2013;2013:3606-3609.
65. Gallego JA, Rocon E, Belda-Lois JM, Pons JL. A neuroprosthesis for tremor management through the control of muscle co-contraction. J Neuroeng Rehabil 2013;10:36.
66. Dosen S, Muceli S, Dideriksen JL, et al. Online tremor suppression using electromyography and low-level electrical stimulation. IEEE Trans Neural Syst Rehabil Eng 2015;23:385-395.
67. Grimaldi G, Manto M, Jdaoudi Y. Quality parameters for a multimodal EEG/EMG/kinematic brain-computer interface (BCI) aiming to suppress neurological tremor in upper limbs. F1000Res 2013;2:282.
68. Taheri B, Case D, Richer E. Robust controller for tremor suppression at musculoskeletal level in human wrist. IEEE Trans Neural Syst Rehabil Eng 2014;22:379-388.
69. Chuanasa J, Songschon S. Essential tremor suppression by a novel self-balancing device. Prosthet Orthot Int 2015;39:219-225.
70. Hashem SY, Zin NA, Yatim NF, Ibrahim NM. Improving mouse controlling and movement for people with Parkinson's disease and involuntary tremor using adaptive path smoothing technique via B-spline. Assist Technol 2014;26:96-104.
71. Pathak A, Redmond JA, Allen M, Chou KL. A noninvasive handheld assistive device to accommodate essential tremor: a pilot study. Mov Disord 2014;29:838-842.
72. Chung SJ, Kwon H, Lee DK, et al. Neuroanatomical heterogeneity of essential tremor according to propranolol response. PLoS One 2013;8:e84054.
73. Elble R, Bain P, Forjaz MJ, et al. Task force report: scales for screening and evaluating tremor: critique and recommendations. Mov Disord 2013;28:1793-1800.
74. Schneider SA, Deuschl G. The treatment of tremor. Neurotherapeutics 2014;11:128-138.